Recombinant multi-species ZBTB7A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZBTB7A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Enables several functions, including SMAD binding activity; nuclear androgen receptor binding activity; and transcription corepressor binding activity. Involved in several processes, including erythrocyte maturation; negative regulation of signal transduction; and regulation of nucleobase-containing compound metabolic process. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Feb 2025]
The Alternative Names of target: 9030619K07Rik,9130006G12Rik,FBI-1,FBI1,Factor binding IST protein 1 (FBI-1),Factor that binds to inducer of short transcripts protein 1,HIV-1 1st-binding protein 1,LRF,Leukemia/lymphoma-related factor,Lrf,MNDLFH,OCZF,POZ and Krueppel erythroid myeloid ontogenic factor (POK erythroid myeloid ontogenic factor,Pokemon,Pokemon 1),TIP21,TTF-I-interacting peptide 21 (TIP21),ZBTB7,ZBTB7A,ZNF857A,Zbtb7,Zbtb7a,Zinc finger and BTB domain-containing protein 7A,Zinc finger protein 857A,pokemon

Target products collectionGo to ZBTB7A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP9398-Ag-1/ GM-Tg-hg-IP9398-Ag-2 Human ZBTB7A protein Human
GM-Tg-rg-IP9398-Ag-1/ GM-Tg-rg-IP9398-Ag-2 Rat ZBTB7A protein Rat
GM-Tg-mg-IP9398-Ag-1/ GM-Tg-mg-IP9398-Ag-2 Mouse ZBTB7A protein Mouse
GM-Tg-cynog-IP9398-Ag-1/ GM-Tg-cynog-IP9398-Ag-2 Cynomolgus/Rhesus macaque ZBTB7A protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP9398-Ag-1/ GM-Tg-felg-IP9398-Ag-2 Feline ZBTB7A protein Feline
GM-Tg-cang-IP9398-Ag-1/ GM-Tg-cang-IP9398-Ag-2 Canine ZBTB7A protein Canine
GM-Tg-bovg-IP9398-Ag-1/ GM-Tg-bovg-IP9398-Ag-2 Bovine ZBTB7A protein Bovine
GM-Tg-equg-IP9398-Ag-1/ GM-Tg-equg-IP9398-Ag-2 Equine ZBTB7A protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP9398-Ag-1/ GM-Tg-hg-IP9398-Ag-2; GM-Tg-rg-IP9398-Ag-1/ GM-Tg-rg-IP9398-Ag-2;
GM-Tg-mg-IP9398-Ag-1/ GM-Tg-mg-IP9398-Ag-2; GM-Tg-cynog-IP9398-Ag-1/ GM-Tg-cynog-IP9398-Ag-2;
GM-Tg-felg-IP9398-Ag-1/ GM-Tg-felg-IP9398-Ag-2; GM-Tg-cang-IP9398-Ag-1/ GM-Tg-cang-IP9398-Ag-2;
GM-Tg-bovg-IP9398-Ag-1/ GM-Tg-bovg-IP9398-Ag-2; GM-Tg-equg-IP9398-Ag-1/ GM-Tg-equg-IP9398-Ag-2
Products Name ZBTB7A protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ZBTB7A
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZBTB7A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.